Menin deficiency in high-fat diet (HFD) models leads to hepatic steatosis, while menin overexpression reduces triglyceride accumulation, suggesting the menin-SIRT1 axis as a potential therapeutic target for hepatic steatosis and age-related metabolic disorders (Cao et al., 2013). This evidence concerns the gene SIRT1 and metabolic disease.